As of May 2024 Hanmi Pharmaceutical has a market cap of $1.70 Billion. This makes Hanmi Pharmaceutical the world's 4443th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.70 B | -17.25% |
2023 | $2.05 B | 17.26% |
2022 | $1.75 B | -42.72% |
2021 | $3.06 B | -33.68% |
2020 | $4.62 B | 115.4% |
2019 | $2.14 B | -51.25% |
2018 | $4.40 B | -31.82% |
2017 | $6.45 B | 123.4% |
2016 | $2.88 B | -52.34% |
2015 | $6.06 B | 716.9% |
2014 | $0.74 B | 23.44% |
2013 | $0.60 B | 73.68% |
2012 | $0.34 B | 96.31% |
2011 | $0.17 B | -39.45% |
2010 | $0.29 B | -69.3% |
2009 | $0.94 B | 30.87% |
2008 | $0.72 B | -49.68% |
2007 | $1.44 B |
On May 18th, 2024 the market cap of Hanmi Pharmaceutical was reported to be: